A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...

Hidden Creek Wellness Retreat supports adolescents struggling with substance use through therapy, recovery programs, ...

Tracking over 600,000 veterans shows that GLP-1 receptor agonists are linked to lower rates of substance use disorders, fewer overdoses, and fewer addiction-related hospital visits.

Kara Stainbrook depended on alcohol to get through the day for two years. The 45-year-old from Mercer, Pennsylvania, was going through a bottle of vodka a week, sometimes two, and hiding it from her ...

The massively popular drugs known as GLP-1 agonists could even halve people's risk of dying from a range of harmful substances, according to the research published in the BMJ journal.

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.